All Type of News
Who will be new KPMA head?
The pharmaceutical market is paying attention to board of directors of the Korea Pharmaceutical Manufacturers Association who have resumed efforts to find a new president of the association.
KPMA said its board has...
Bukwang beset by groundless M&A rumors
Bukwang Pharm is concerned over a drop in its stock prices due to rumors of its takeover by a multinational pharmaceutical firm.
The company has repeatedly denied any M&A scenarios, but its stock prices plummeted f...
KCDC’s Chun becomes Health Ministry spokesman
Chun Byung-ryul, incumbent director of the Korea Centers for Disease Control and Prevention (KCDC), started work this month as the spokesman for the Ministry of Health, Welfare and Family Affairs, the ministry said on...
Drugmakers support unified drug distribution system
Korean pharmaceutical firms are expressing their serious concerns over the government’s plan to scrap the unified drug distribution system from December 31, this year, according to pharmaceutical sources.
In a rece...
Dong-A to conduct phase I trial for new treatment of premature ejaculation
Dong-A Pharmaceutical Co. said on May 4 it will conduct its Phase I trial for a new medicine (codename: DA-8031) for the treatment of premature ejaculation (PE).
The company said the study will be conducted in Seou...
Zuellig Pharma displeased at ex-president’s disclosure
Headquarters of Zuellig Pharma has expressed to Christian Stoeckling, ex-president of Zuellig Pharma Korea, over his remarks on April 30.
“We expressed our displeasure and will resort to legal action against Stoeck...
Government seeking extension of whistleblowers reward to pharmaceutical industry
Whistleblowers - those who report illegal rebate practices offered by pharmaceutical companies to the authorities – will be given in cash from this month, the Fair Trade Commission said on May 4.
The commission sai...
Dong-A Pharm acquires Samchully Pharm for 50 billion won
Dong-A Pharmaceutical Co., the top Korean drug maker, said on May 4 that it has struck a deal to take over Samchully Pharm for 50 billion won in its first acquisition of a domestic company.
“It will help us make in...
Green Cross to produce local tuberculosis vaccine
Green Cross, one of the nation's biggest pharmaceutical companies, said it will start production of its tuberculosis vaccine in 2014, which will be backed by the Korean government.
To this end, the company held a g...
Health ministry to get tough on monitoring of long-term care hospitals
The Ministry of Health and Welfare will strengthen its duty in monitoring long-term care hospitals, taking follow-up measures against overcharging cases within the year.
Since January 2008, the government has adjus...
